Anixa Biosciences Inc Quarterly Operating Lease, Liability in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Anixa Biosciences Inc quarterly Operating Lease, Liability history and growth rate from Q3 2019 to Q3 2024.
  • Anixa Biosciences Inc Operating Lease, Liability for the quarter ending October 31, 2024 was $232K, a 32.6% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $232K +$57K +32.6% Oct 31, 2024 10-K 2025-01-10
Q2 2024 $237K +$50K +26.7% Jul 31, 2024 10-Q 2024-09-06
Q1 2024 $149K -$49K -24.7% Apr 30, 2024 10-Q 2024-06-04
Q4 2023 $162K -$47K -22.5% Jan 31, 2024 10-Q 2024-03-12
Q3 2023 $175K -$46K -20.8% Oct 31, 2023 10-K 2024-01-16
Q2 2023 $187K -$44K -19% Jul 31, 2023 10-Q 2023-09-06
Q1 2023 $198K -$43K -17.8% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $209K +$209K Jan 31, 2023 10-Q 2023-03-17
Q3 2022 $221K -$38.5K -14.8% Oct 31, 2022 10-K 2023-01-04
Q2 2022 $231K +$220K +2086% Jul 31, 2022 10-Q 2022-09-09
Q1 2022 $241K +$215K +828% Apr 30, 2022 10-Q 2022-06-10
Q4 2021 $250* -$40.6K Jan 31, 2022 10-Q 2022-03-11
Q3 2021 $259K +$204K +370% Oct 31, 2021 10-K 2022-01-04
Q2 2021 $10.6K -$58.2K -84.6% Jul 31, 2021 10-Q 2021-09-01
Q1 2021 $26K -$55.7K -68.2% Apr 30, 2021 10-Q 2021-06-10
Q4 2020 $40.8K -$53.4K -56.7% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 $55.2K -$51.1K -48.1% Oct 31, 2020 10-K 2021-01-07
Q2 2020 $68.8K Jul 31, 2020 10-Q 2020-09-08
Q1 2020 $81.7K Apr 30, 2020 10-Q 2020-06-09
Q4 2019 $94.2K Jan 31, 2020 10-Q 2020-03-09
Q3 2019 $106K Nov 1, 2019 10-Q 2020-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.